Search by Drug Name or NDC
NDC 00404-9990-20 ATROPINE SULFATE 0.4 mg/mL Details
ATROPINE SULFATE 0.4 mg/mL
ATROPINE SULFATE is a ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Henry Schein, Inc.. The primary component is ATROPINE SULFATE.
Product Information
| NDC | 00404-9990 |
|---|---|
| Product ID | 0404-9990_3fbc391e-8c26-4b3a-9de6-aa1c4689161a |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | ATROPINE SULFATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | atropine sulfate injection |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 0.4 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATROPINE SULFATE |
| Labeler Name | Henry Schein, Inc. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213561 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00404-9990-20 (00404999020)
| NDC Package Code | 0404-9990-20 |
|---|---|
| Billing NDC | 00404999020 |
| Package | 1 PACKAGE in 1 BAG (0404-9990-20) / 20 mL in 1 PACKAGE |
| Marketing Start Date | 2022-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |